Jump Financial, LLC Kezar Life Sciences, Inc. Transaction History

Jump Financial, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.53 - $0.77 $11,991 - $17,421	-22,625 Closed	0 $0
Q2 2024 Aug 14, 2024	BUY	$0.6 - $0.92 $13,575 - $20,815	22,625 New	22,625 $13,000
Q2 2023 Oct 21, 2024	SELL	$2.31 - $3.06 $267,036 - $353,736	-115,600 Reduced 71.23%	46,700 $114,000
Q2 2023 Aug 07, 2023	SELL	$2.31 - $3.06 $267,036 - $353,736	-115,600 Reduced 71.23%	46,700 $114,000
Q1 2023 Oct 21, 2024	BUY	$3.13 - $7.31 $437,182 - $1.02 Million	139,675 Added 617.35%	162,300 $507,000
Q1 2023 May 03, 2023	BUY	$3.13 - $7.31 $472,996 - $1.1 Million	151,117 Added 1351.31%	162,300 $507,000
Q4 2022 Feb 13, 2023	BUY	$6.39 - $8.8 $71,459 - $98,410	11,183 New	11,183 $78,000

38.4M

13.8K

600

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $440M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.